Comparison of the Treatment Efficacy of Rituximab and Plasmapheresis/Intravenous Immunoglobulin Combination with Historical Control in Chronic Antibody Mediated Rejection

RUHİ, CAGLAR; Tuğcu, Murat; Kasapoğlu, Umut; Gökçe, Ali; ATA, PINAR; TİTİZ, MESUT

doi:10.5262/tndt.2017.1001.08

Comparison of the Treatment Efficacy of Rituximab and Plasmapheresis/Intravenous Immunoglobulin Combination with Historical Control in Chronic Antibody Mediated Rejection

RUHİ B. Ç., Tuğcu M., Kasapoğlu U., Gökçe A. M., ATA P., TİTİZ M. İ.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, cilt.26, sa.1, ss.48-54, 2017 (Hakemli Dergi)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 26 Sayı: 1
Basım Tarihi: 2017
Doi Numarası: 10.5262/tndt.2017.1001.08
Dergi Adı: TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL
Sayfa Sayıları: ss.48-54
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

OBJECTIVE: Chronic antibody mediated rejection (CAMR) is a major therapeutic challenge for achieving long-term graft survival; treatment options are limited to several anti-humoral interventions.